Tradestie Institutional Equity Comparison Engine
SABA vs ACTU โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SABA Overall Edge
SABA Captures Institutional Edge (2โ1 Pillars ยท 4โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Saba Capital Income & Opportunities Fund II (SABA) driven by superior Momentum & Technical, Options & Structure while ACTU counters with relative strength in Growth & Margin. Fundamentally, SABA trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ACTU at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, SABA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ACTU sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
SABA N/M vs ACTU N/M Fwd P/E
Growth & Margin Winner
ACTU
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner
SABA
1Y -16.0% vs -96.2% ยท 52W Pos 4% vs 1%
Options & Structure Winner
SABA
UNCLASSIFIED (N/A IV) vs BREAKDOWN (N/A IV)
SABA
NYSE
Saba Capital Income & Opportunities Fund II
Institutional Equity
$7.33
-0.27% 1D
Market Cap
$251.8M
1M Return
-3.68%
1Y Return
-16.04%
Forward P/E
N/M
Unified AI Score
44.2 / 100
HOLD
Tech 38.0
Fund 55.0
Flow 50.0
Mom 55.0
ACTU
NASDAQ
Actuate Therapeutics, Inc. Common stock
Pharmaceutical Preparations
$0.23
+5.38% 1D
Market Cap
$12.9M
1M Return
-56.35%
1Y Return
-96.15%
Forward P/E
N/M
Unified AI Score
35.1 / 100
SELL
Tech 25.0
Fund 37.0
Flow 50.0
Mom 49.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SABA -16.04%
ACTU -96.15%
Spread: +80.11 pp (SABA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
SABA TTM Op. Margin: N/A
ACTU TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SABA vs ACTU. Trailing 12-month operating profitability (SABA N/A vs ACTU 0.0%) and valuation multiples (SABA N/M vs ACTU N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SABA | ACTU | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $251.8M | $12.9M | Larger Scale | SABA |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | +0.0% | Higher Growth | ACTU |
| Operating Margin (TTM) Profitability | N/A | 0.0% | Higher Margin | ACTU |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | ACTU |
| Return on Equity (ROE) Capital Efficiency | N/A | -553.8% | Higher ROE | ACTU |
| 52-Week Range Position Momentum | 4% ($7โ$9) | 1% ($0โ$8) | Stronger Trend | SABA |
| Beta / 30D Volatility Risk Regime | 0.37ฮฒ ยท 13% Vol | 1.64ฮฒ ยท 114% Vol | Lower Realized Risk | SABA |
| Unified Institutional Score Composite Signal | 44.2 / 100 (HOLD) | 35.1 / 100 (SELL) | Higher Composite | SABA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SABA vs ACTU Buy Guide
SABA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ACTU
BREAKDOWN
136d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SABA nor ACTU registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.